Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · Real-Time Price · USD

14.48

-0.92 (-5.97%)

At close: Jan 30, 2026, 4:00 PM EST

14.30

-0.18 (-1.24%)

After-hours: Jan 30, 2026, 7:58 PM EST

Summit Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	11,166	13,160	1,829	897	263	387
Market Cap Growth	-9.06%	619.43%	103.94%	241.23%	-32.01%	-28.06%
Enterprise Value	10,933	12,705	1,737	779	184	366
Last Close Price	14.48	17.84	2.61	4.25	2.69	4.70
PS Ratio	-	-	-	1272.24	145.30	449.56
PB Ratio	56.07	33.85	23.54	7.08	3.16	4.87
P/TBV Ratio	58.69	34.02	24.13	7.18	3.71	5.87
EV/Sales Ratio	-	-	-	1105.42	101.96	425.47
Debt / Equity Ratio	0.03	0.02	1.37	4.10	0.03	0.01
Asset Turnover	-	-	-	0.00	0.02	0.01
Quick Ratio	3.67	9.90	9.17	9.15	3.47	3.85
Current Ratio	3.80	10.15	9.30	16.93	3.80	4.41
Return on Equity (ROE)	-292.49%	-94.89%	-601.85%	-75.05%	-108.89%	-66.57%
Return on Assets (ROA)	-152.88%	-41.30%	-12.79%	-10.23%	-49.91%	-32.91%
Return on Capital Employed (ROCE)	-475.20%	-53.60%	-48.60%	-10.20%	-98.20%	-63.40%
Earnings Yield	-8.25%	-1.68%	-33.62%	-8.78%	-33.71%	-13.63%
FCF Yield	-2.42%	-1.08%	-4.20%	-4.71%	-27.73%	-12.55%
Buyback Yield / Dilution	-4.36%	-15.96%	-220.50%	-109.60%	-32.67%	-111.78%

Updated Oct 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q